Filing metadata

Accession number
0001214659-16-011134
Form type
Form 4
Filer
Anthera Pharmaceuticals Inc
CIK
CIK 1316175
Filed
Apr 29, 2016
Reporting period
May 21, 2015
Description
Insider transaction

Explore SEC Filings Hub